163 related articles for article (PubMed ID: 35604668)
1. MRI radiomics combined with clinicopathologic features to predict disease-free survival in patients with early-stage cervical cancer.
Jiang X; Song J; Duan S; Cheng W; Chen T; Liu X
Br J Radiol; 2022 Aug; 95(1136):20211229. PubMed ID: 35604668
[TBL] [Abstract][Full Text] [Related]
2. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
[TBL] [Abstract][Full Text] [Related]
4. An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer.
Zheng RR; Cai MT; Lan L; Huang XW; Yang YJ; Powell M; Lin F
Br J Radiol; 2022 Jan; 95(1129):20210838. PubMed ID: 34797703
[TBL] [Abstract][Full Text] [Related]
5. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
[TBL] [Abstract][Full Text] [Related]
6. Added value of radiomics analysis in MRI invisible early-stage cervical cancers.
Hu Q; Shi J; Zhang A; Duan S; Song J; Chen T
Br J Radiol; 2022 May; 95(1133):20210986. PubMed ID: 35143254
[TBL] [Abstract][Full Text] [Related]
7. MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
Liu Y; Dong TF; Li PJ; Chen LB; Song T
Magn Reson Imaging; 2024 Jul; 110():170-175. PubMed ID: 38035947
[TBL] [Abstract][Full Text] [Related]
8. Radiomics nomogram for predicting disease-free survival after partial resection or radical cystectomy in patients with bladder cancer.
Cai Q; Huang Y; Ling J; Kong L; Lin Y; Chen Y; Cao W; Liao Y; Guo Y; Guan J; Wang H
Br J Radiol; 2024 Jan; 97(1153):201-209. PubMed ID: 38263836
[TBL] [Abstract][Full Text] [Related]
9. MRI-derived radiomics analysis improves the noninvasive pretreatment identification of multimodality therapy candidates with early-stage cervical cancer.
Li Y; Ren J; Yang JJ; Cao Y; Xia C; Lee EYP; Chen B; Guan H; Qi YF; Gao X; Tang W; Chen K; Jin ZY; He YL; Xiang Y; Xue HD
Eur Radiol; 2022 Jun; 32(6):3985-3995. PubMed ID: 35018480
[TBL] [Abstract][Full Text] [Related]
10. Predicting Disease-Free Survival With Multiparametric MRI-Derived Radiomic Signature in Cervical Cancer Patients Underwent CCRT.
Liu B; Sun Z; Xu ZL; Zhao HL; Wen DD; Li YA; Zhang F; Hou BX; Huan Y; Wei LC; Zheng MW
Front Oncol; 2021; 11():812993. PubMed ID: 35145910
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram.
Li J; Zhou H; Lu X; Wang Y; Pang H; Cesar D; Liu A; Zhou P
BMC Med Imaging; 2023 Oct; 23(1):153. PubMed ID: 37821840
[TBL] [Abstract][Full Text] [Related]
12. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
[TBL] [Abstract][Full Text] [Related]
13. Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.
Liu S; Li R; Liu Q; Sun D; Yang H; Pan H; Wang L; Song S
Cancer Biomark; 2022; 33(2):249-259. PubMed ID: 35213357
[TBL] [Abstract][Full Text] [Related]
14. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
[TBL] [Abstract][Full Text] [Related]
15. MRI-based radiomics analysis to evaluate the clinicopathological characteristics of cervical carcinoma: a multicenter study.
Liu Y; Song T; Dong TF; Zhang W; Wen G
Acta Radiol; 2023 Jan; 64(1):395-403. PubMed ID: 34918963
[TBL] [Abstract][Full Text] [Related]
16. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.
Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
[TBL] [Abstract][Full Text] [Related]
18. MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.
Wagner-Larsen KS; Hodneland E; Fasmer KE; Lura N; Woie K; Bertelsen BI; Salvesen Ø; Halle MK; Smit N; Krakstad C; Haldorsen IS
Cancer Med; 2023 Oct; 12(20):20251-20265. PubMed ID: 37840437
[TBL] [Abstract][Full Text] [Related]
19. Classifying early stages of cervical cancer with MRI-based radiomics.
Zhao X; Wang X; Zhang B; Liu X; Xuan D; Xia Y; Zhang X
Magn Reson Imaging; 2022 Jun; 89():70-76. PubMed ID: 35337907
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Assessment of MRI-Invisible Early-Stage Endometrial Cancer With MRI-Based Radiomics Analysis.
Jiang X; Song J; Zhang A; Cheng W; Duan S; Liu X; Chen T
J Magn Reson Imaging; 2023 Jul; 58(1):247-255. PubMed ID: 36259352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
